Skip to content
The Longevity Archive
Danuglipron in all countries

Legal status · United Kingdom

Is Danuglipron legal in the United Kingdom?

InvestigationalMetabolicEvidence: Preliminary

No. Danuglipron is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.

Danuglipron in the United Kingdom at a glance

ClassificationInvestigational, not licensed
MHRA approval statusNot approved by MHRA; investigational
Evidence levelPreliminary (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Danuglipron profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    Danuglipron is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Danuglipron is

Pfizer's oral small-molecule GLP-1 agonist whose development was discontinued after tolerability and safety signals.

Danuglipron was Pfizer's attempt at an oral small-molecule GLP-1 agonist to compete with injectable peptides. Despite showing weight loss in trials, the program faced high rates of gastrointestinal side effects and a liver-enzyme safety signal, and Pfizer discontinued its development.

Mechanism: Activates the GLP-1 receptor as an orally available small molecule rather than an injected peptide.

Regulatory history: Development discontinued; not approved

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Danuglipron at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Danuglipron in other countries

Frequently asked questions

Is Danuglipron legal in the United Kingdom?

No. Danuglipron is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.

Can I buy Danuglipron in the United Kingdom?

No approved product exists to buy. In the United Kingdom Danuglipron is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Danuglipron MHRA approved?

No. In the United Kingdom Danuglipron is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Development discontinued; not approved. Evidence level: Preliminary.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Danuglipron live on its compound profile.

Danuglipron profile

This page is general information about the regulatory status of Danuglipron in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.